Standout Papers

A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combinat... 2000 2026 2008 2017 846
  1. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer (2000)
    Fadlo R. Khuri, John Nemunaitis et al. Nature Medicine

Immediate Impact

8 by Nobel laureates 20 from Science/Nature 67 standout
Sub-graph 1 of 20

Citing Papers

An oncolytic virus–T cell chimera for cancer immunotherapy
2024 Standout
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
17 intermediate papers

Works of Britta Randlev being referenced

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
2001 Nobel
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
2000 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
Britta Randlev 1528 2096 1588 14 2.6k
Shaoheng Ni 895 1659 1302 27 2.1k
Adam Sampson-Johannes 1800 2387 2241 18 3.9k
Galina Mikheeva 1283 2134 1860 30 2.6k
Dechao Yu 1181 1510 1369 57 2.6k
Zong-Yi Li 741 1436 1108 23 1.9k
Gustavo Droguett 1103 2509 2056 11 3.5k
Manijeh Daneshmand 2250 1119 1187 34 3.5k
Ada Houweling 958 1780 1812 28 2.8k
Jennifer Cunningham 890 1993 1451 8 2.8k
Karen Buchkovich 2206 1153 1872 14 3.5k

All Works

Loading papers...

Rankless by CCL
2026